Whales with a lot of money to spend have taken a noticeably bullish stance on Recursion Pharmaceuticals.
Looking at options history for Recursion Pharmaceuticals RXRX we detected 8 trades.
If we consider the specifics of each trade, it is accurate to state that 75% of the investors opened trades with bullish expectations and 25% with bearish.
From the overall spotted trades, 2 are puts, for a total amount of $141,300 and 6, calls, for a total amount of $207,580.
Predicted Price Range
Analyzing the Volume and Open Interest in these contracts, it seems that the big players have been eyeing a price window from $7.0 to $15.0 for Recursion Pharmaceuticals during the past quarter.
Volume & Open Interest Development
Examining the volume and open interest provides crucial insights into stock research. This information is key in gauging liquidity and interest levels for Recursion Pharmaceuticals's options at certain strike prices. Below, we present a snapshot of the trends in volume and open interest for calls and puts across Recursion Pharmaceuticals's significant trades, within a strike price range of $7.0 to $15.0, over the past month.
Recursion Pharmaceuticals Call and Put Volume: 30-Day Overview
Largest Options Trades Observed:
| Symbol | PUT/CALL | Trade Type | Sentiment | Exp. Date | Ask | Bid | Price | Strike Price | Total Trade Price | Open Interest | Volume |
|---|---|---|---|---|---|---|---|---|---|---|---|
| RXRX | PUT | SWEEP | BULLISH | 06/20/25 | $3.7 | $3.5 | $3.5 | $10.00 | $102.9K | 14 | 298 |
| RXRX | CALL | SWEEP | BULLISH | 01/16/26 | $1.9 | $1.7 | $1.9 | $15.00 | $47.5K | 1.9K | 416 |
| RXRX | CALL | TRADE | BULLISH | 01/24/25 | $2.15 | $2.1 | $2.15 | $8.00 | $43.0K | 256 | 200 |
| RXRX | PUT | SWEEP | BULLISH | 03/21/25 | $3.2 | $3.0 | $3.0 | $10.00 | $38.4K | 976 | 129 |
| RXRX | CALL | TRADE | BEARISH | 01/16/26 | $3.9 | $3.3 | $3.5 | $7.50 | $35.0K | 4.5K | 176 |
About Recursion Pharmaceuticals
Recursion Pharmaceuticals Inc is a clinical-stage biotechnology company. It is decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering, with the goal of radically improving the lives of patients and industrializing drug discovery.
In light of the recent options history for Recursion Pharmaceuticals, it's now appropriate to focus on the company itself. We aim to explore its current performance.
Current Position of Recursion Pharmaceuticals
- Currently trading with a volume of 8,975,175, the RXRX's price is down by -6.89%, now at $7.7.
- RSI readings suggest the stock is currently may be approaching overbought.
- Anticipated earnings release is in 77 days.
What The Experts Say On Recursion Pharmaceuticals
1 market experts have recently issued ratings for this stock, with a consensus target price of $11.0.
Turn $1000 into $1270 in just 20 days?
20-year pro options trader reveals his one-line chart technique that shows when to buy and sell. Copy his trades, which have had averaged a 27% profit every 20 days. Click here for access. * In a cautious move, an analyst from Needham downgraded its rating to Buy, setting a price target of $11.
Options are a riskier asset compared to just trading the stock, but they have higher profit potential. Serious options traders manage this risk by educating themselves daily, scaling in and out of trades, following more than one indicator, and following the markets closely.
If you want to stay updated on the latest options trades for Recursion Pharmaceuticals, Benzinga Pro gives you real-time options trades alerts.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
